Next-generation probiotics: an outlook into current applications and future developments

Hill, C. et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11 , 506–514 (2014). PubMed Google Scholar Liu, H. et al. A multicellular self-organized probiotic platform for oral delivery enhances intestinal colonization. Nat. Commun. 16 , 7060 (2025). CAS PubMed PubMed Central Google Scholar Konstantinov, S. R. et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl Acad. Sci. USA 105 , 19474–19479 (2008). CAS PubMed PubMed Central Google Scholar Asare, P. T. et al. Reuterin demonstrates potent antimicrobial activity against a broad panel of human and poultry meat Campylobacter spp. isolates. Microorganisms 8 , 78 (2020). CAS PubMed PubMed Central Google Scholar Rutter, J. W. et al. A bacteriocin expression platform for targeting pathogenic bacterial species. Nat. Commun. 15 , 6332 (2024). CAS PubMed PubMed Central Google Scholar Kamada, N. et al. Nonpathogenic Escherichia coli strain Nissle 1917 inhibits signal transduction in intestinal epithelial cells. Infect. Immun. 76 , 214–220 (2008). CAS PubMed Google Scholar Baralić, K., Živančević, K., Bozic, D. & Đukić-Ćosić, D. Probiotic cultures as a potential protective strategy against the toxicity of environmentally relevant chemicals: state-of-the-art knowledge. Food Chem. Toxicol. 172 , 113582 (2023). PubMed Google Scholar O’Toole, P. W., Marchesi, J. R. & Hill, C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 2 , 17057 (2017). PubMed Google Scholar Suez, J., Zmora, N., Segal, E. & Elinav, E. The pros, cons, and many unknowns of probiotics. Nat. Med. 25 , 716–729 (2019). CAS PubMed Google Scholar Baião, R. et al. Multispecies probiotic administration reduces emotional salience and improves mood in subjects with moderate depression: a randomised, double-blind, placebo-controlled study. Psychol. Med. 53 , 3437–3447 (2023). PubMed Google Scholar Asghari, K. M. et al. The effect of probiotic supplementation on the clinical and para-clinical findings of multiple sclerosis: a randomized clinical trial. Sci. Rep. 13 , 18577 (2023). CAS PubMed PubMed Central Google Scholar Gibson, G. R. et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 14 , 491–502 (2017). PubMed Google Scholar Hutkins, R. et al. Classifying compounds as prebiotics — scientific perspectives and recommendations. Nat. Rev. Gastroenterol. Hepatol. 22 , 54–70 (2025). PubMed Google Scholar Swanson, K. S. et al. The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nat. Rev. Gastroenterol. Hepatol. 17 , 687–701 (2020). PubMed PubMed Central Google Scholar Lewis, Z. T. et al. Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr. Res. 79 , 445–452 (2016). CAS PubMed Google Scholar MarketsandMarkets. Probiotics Market Report (Global Forecast to 2029) (MarketsandMarkets, 2025). McFarland, L. V. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J. Gastroenterol. 16 , 2202–2222 (2010). PubMed PubMed Central Google Scholar Li, M. et al. Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery. Biomaterials 309 , 122584 (2024). CAS PubMed Google Scholar Allegretti, J. R. et al. Safety and efficacy of fecal microbiota, live-jslm (REBYOTA®), for the prevention of recurrent Clostridioides difficile infection in participants with inflammatory bowel disease in PUNCH CD3-OLS. Inflamm. Bowel Dis. 31 , 2112–2122 (2025). PubMed PubMed Central Google Scholar Rosenberg, J. & Ritter, T. Practical use of fecal microbiota spores, live-brpk (formerly SER-109): an oral therapeutic for the prevention of recurrent Clostridioides difficile infection. Expert Rev. Antiinfect. Ther. 21 , 687–690 (2023). CAS Google Scholar Feuerstadt, P. et al. SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection. N. Engl. J. Med. 386 , 220–229 (2022). CAS PubMed Google Scholar Khanna, S. et al. Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a Bayesian primary analysis for the prevention of recurrent Clostridioides difficile infection. Drugs 82 , 1527–1538 (2022). CAS PubMed PubMed Central Google Scholar Peled, J. U. et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 382 , 822–834 (2020). CAS PubMed PubMed Central Google Scholar Rashidi, A. et al. Randomized double-blind phase II trial of fecal microbiota transplantation versus placebo in allogeneic hematopoietic cell transplantation and AML. J. Clin. Oncol. 41 , 5306–5319 (2023). CAS PubMed PubMed Central Google Scholar Veiga, P., Suez, J., Derrien, M. & Elinav, E. Moving from probiotics to precision probiotics. Nat. Microbiol. 5 , 878–880 (2020). PubMed Google Scholar Zmora, N. et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174 , 1388–1405.e21 (2018). CAS PubMed Google Scholar Hernández Medina, R. et al. Machine learning and deep learning applications in microbiome research. ISME Commun. 2 , 98 (2022). PubMed PubMed Central Google Scholar Marcos-Zambrano, L. J. et al. Applications of machine learning in human microbiome studies: a review on feature selection, biomarker identification, disease prediction and treatment. Front. Microbiol. 12 , 634511 (2021). PubMed PubMed Central Google Scholar Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473 , 174–180 (2011). CAS PubMed PubMed Central Google Scholar Li, N. & Guo, X. The gut microbiota and host immunity synergistically orchestrate colonization resistance. Gut Microbes 18 , 2611545 (2026). PubMed PubMed Central Google Scholar Merenstein, D. J. et al. Is there evidence to support probiotic use for healthy people? Adv. Nutr. 15 , 100265 (2024). PubMed PubMed Central Google Scholar McFarland, L. V., Evans, C. T. & Goldstein, E. J. C. Strain-specificity and disease-specificity of probiotic efficacy: a systematic review and meta-analysis. Front. Med. 5 , 124 (2018). Google Scholar Kochan, P. et al. Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient — is the time right to revise probiotic safety guidelines? Clin. Microbiol. Infect. 17 , 1589–1592 (2011). CAS PubMed Google Scholar Land, M. H. et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115 , 178–181 (2005). PubMed Google Scholar Suez, J. et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell 174 , 1406–1423.e16 (2018). CAS PubMed Google Scholar Zhang, W. et al. Bacteroides fragilis protects against antibiotic-associated diarrhea in rats by modulating intestinal defenses. Front. Immunol. 9 , 1040 (2018). PubMed PubMed Central Google Scholar Kang, C.-H. et al. Pasteurized Akkermansia muciniphila HB05 (HB05P) improves muscle strength and function: a 12-week, randomized, double-blind, placebo-controlled clinical trial. Nutrients 16 , 4037 (2024). CAS PubMed PubMed Central Google Scholar Zhang, H. et al. Akkermansia muciniphila ONE effectively ameliorates dextran sulfate sodium (DSS)-induced ulcerative colitis in mice. npj Sci. Food 8 , 97 (2024). CAS PubMed PubMed Central Google Scholar Xiao, X. et al. Akkermansia muciniphila supplementation improves hyperlipidemia, cardiac function, and gut microbiota in high fat fed apolipoprotein E-deficient mice. Prostaglandins Other Lipid Mediat. 175 , 106906 (2024). CAS PubMed Google Scholar Blacher, E. et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 572 , 474–480 (2019). CAS PubMed Google Scholar Desai, M. S. et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167 , 1339–1353.e21 (2016). CAS PubMed PubMed Central Google Scholar Cox, L. M. et al. Gut microbiome in progressive multiple sclerosis. Ann. Neurol. 89 , 1195–1211 (2021). CAS PubMed PubMed Central Google Scholar Walter, J., Maldonado-Gómez, M. X. & Martínez, I. To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes. Curr. Opin. Biotechnol. 49 , 129–139 (2018). CAS PubMed Google Scholar Shen, X. et al. Short-term probiotic supplementation affects the diversity, genetics, growth, and interactions of the native gut microbiome. iMeta 3 , e253 (2024). CAS PubMed PubMed Central Google Scholar Maldonado-Gómez, M. X. et al. Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host Microbe 20 , 515–526 (2016). PubMed Google Scholar Chávarri, M. et al. Microencapsulation of a probiotic and prebiotic in alginate-chitosan capsules improves survival in simulated gastro-intestinal conditions. Int. J. Food Microbiol. 142 , 185–189 (2010). PubMed Google Scholar Cook, M. T., Tzortzis, G., Charalampopoulos, D. & Khutoryanskiy, V. V. Microencapsulation of probiotics for gastrointestinal delivery. J. Control. Release 162 , 56–67 (2012). CAS PubMed Google Scholar Tremblay, A. et al. Total transit time and probiotic persistence in healthy adults: a pilot study. J. Neurogastroenterol. Motil. 29 , 218–228 (2023). PubMed PubMed Central Google Scholar Singhal, R. & Shah, Y. M. Oxygen battle in the gut: hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine. J. Biol. Chem. 295 , 10493–10505 (2020). CAS PubMed PubMed Central Google Scholar Kiu, R. et al. Particular genomic and virulence traits associated with preterm infant-derived toxigenic Clostridium perfringens strains. Nat. Microbiol. 8 , 1160–1175 (2023). CAS PubMed PubMed Central Google Scholar Baishya, J. et al. The impact of intraspecies and interspecies bacterial interactions on disease outcome. Pathogens 10 , 96 (2021). CAS PubMed PubMed Central Google Scholar Holzapfel, W., Arini, A., Aeschbacher, M., Coppolecchia, R. & Pot, B. Enterococcus faecium SF68 as a model for efficacy and safety evaluation of pharmaceutical probiotics. Benef. Microbes 9 , 375–388 (2018). CAS PubMed Google Scholar Montealegre, M. C., Singh, K. V. & Murray, B. E. Gastrointestinal tract colonization dynamics by different Enterococcus faecium clades. J. Infect. Dis. 213 , 1914–1922 (2016). PubMed Google Scholar Leendertse, M. et al. Enterococcal surface protein transiently aggravates Enterococcus faecium -induced urinary tract infection in mice. J. Infect. Dis. 200 , 1162–1165 (2009). CAS PubMed Google Scholar Leavis, H. L., Willems, R. J. L., Top, J. & Bonten, M. J. M. High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium . J. Clin. Microbiol. 44 , 1059–1064 (2006). CAS PubMed PubMed Central Google Scholar Torres, M. et al. Bacterial fitness for plant colonization is influenced by plant growth substrate. N. Phytol. 248 , 3168–3190 (2025). CAS Google Scholar Han, S. et al. Probiotic gastrointestinal transit and colonization after oral administration: a long journey. Front. Cell. Infect. Microbiol. 11 , 609722 (2021). CAS PubMed PubMed Central Google Scholar Sassone-Corsi, M. et al. Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature 540 , 280–283 (2016). CAS PubMed PubMed Central Google Scholar Osbelt, L. et al. Variations in microbiota composition of laboratory mice influence Citrobacter rodentium infection via variable short-chain fatty acid production. PLoS Pathog. 16 , e1008448 (2020). CAS PubMed PubMed Central Google Scholar Strock, R. et al. Archaea produce peptidoglycan hydrolases that kill bacteria. PLoS Biol. 23 , e3003235 (2025). CAS PubMed PubMed Central Google Scholar Alavi, S. et al. Interpersonal gut microbiome variation drives susceptibility and resistance to cholera infection. Cell 181 , 1533–1546.e13 (2020). CAS PubMed PubMed Central Google Scholar Long, X. et al. Interindividual variability in gut microbiome mediates the efficacy of resistant starch on MASLD. Cell Metab. 37 , 2342–2361.e9 (2025). CAS PubMed Google Scholar Wang, H. et al. Microbial metabolite deoxycholic acid controls Clostridium perfringens -induced chicken necrotic enteritis through attenuating inflammatory cyclooxygenase signaling. Sci. Rep. 9 , 14541 (2019). PubMed PubMed Central Google Scholar Scott, S. A., Fu, J. & Chang, P. V. Dopamine receptor D2 confers colonization resistance via microbial metabolites. Nature 628 , 180–185 (2024). CAS PubMed PubMed Central Google Scholar Caballero-Flores, G., Pickard, J. M. & Núñez, G. Microbiota-mediated colonization resistance: mechanisms and regulation. Nat. Rev. Microbiol. 21 , 347–360 (2023). CAS PubMed Google Scholar Djukovic, A. et al. Lactobacillus supports Clostridiales to restrict gut colonization by multidrug-resistant Enterobacteriaceae. Nat. Commun. 13 , 5617 (2022). CAS PubMed PubMed Central Google Scholar Foley, M. H. et al. Differential modulation of post-antibiotic colonization resistance to Clostridioides difficile by two probiotic Lactobacillus strains. mBio 16 , e0146825 (2025). PubMed PubMed Central Google Scholar von Meijenfeldt, F. A. B., Hogeweg, P. & Dutilh, B. E. A social niche breadth score reveals niche range strategies of generalists and specialists. Nat. Ecol. Evol. 7 , 768–781 (2023). Google Scholar Bakkeren, E., Piskovsky, V., Lee, M. N. Y., Jahn, M. T. & Foster, K. R. Strain displacement in microbiomes via ecological competition. Nat. Microbiol. 10 , 3122–3135 (2025). CAS PubMed PubMed Central Google Scholar Heilbronner, S., Krismer, B., Brötz-Oesterhelt, H. & Peschel, A. The microbiome-shaping roles of bacteriocins. Nat. Rev. Microbiol. 19 , 726–739 (2021). CAS PubMed Google Scholar Tang, Q. et al. Current sampling methods for gut microbiota: a call for more precise devices. Front. Cell. Infect. Microbiol. 10 , 151 (2020). CAS PubMed PubMed Central Google Scholar Zhang, P. Influence of foods and nutrition on the gut microbiome and implications for intestinal health. Int. J. Mol. Sci. 23 , 9588 (2022). CAS PubMed PubMed Central Google Scholar Tompkins, T. A., Mainville, I. & Arcand, Y. The impact of meals on a probiotic during transit through a model of the human upper gastrointestinal tract. Benef. Microbes 2 , 295–303 (2011). CAS PubMed Google Scholar Fan, P. et al. Host genetic effects upon the early gut microbiota in a bovine model with graduated spectrum of genetic variation. ISME J. 14 , 302–317 (2020). CAS PubMed Google Scholar Federici, S. et al. Targeted suppression of human IBD-associated gut microbiota commensals by phage consortia for treatment of intestinal inflammation. Cell 185 , 2879–2898.e24 (2022). CAS PubMed Google Scholar Zuo, T. et al. Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome. Gut 67 , 634–643 (2018). CAS PubMed Google Scholar Shimizu, K. et al. Identification of genes essential for bile acid resistance in the probiotic Lacticaseibacillus paracasei strain Shirota. Lett. Appl. Microbiol. 76 , ovad062 (2023). CAS PubMed Google Scholar Mays, Z. J. S., Chappell, T. C. & Nair, N. U. Quantifying and engineering mucus adhesion of probiotics. ACS Synth. Biol. 9 , 356–367 (2020). CAS PubMed PubMed Central Google Scholar Khan, M. T. et al. Synergy and oxygen adaptation for development of next-generation probiotics. Nature 620 , 381–385 (2023). CAS PubMed PubMed Central Google Scholar Burrows, K. et al. A gut commensal protozoan determines respiratory disease outcomes by shaping pulmonary immunity. Cell 188 , 316–330.e12 (2025). CAS PubMed Google Scholar Kruger, K. et al. Evaluation of inter- and intra-variability in gut health markers in healthy adults using an optimised faecal sampling and processing method. Sci. Rep. 14 , 24580 (2024). PubMed PubMed Central Google Scholar Rothwell, P. M. External validity of randomised controlled trials: ‘to whom do the results of this trial apply?’. Lancet 365 , 82–93 (2005). PubMed Google Scholar Chuang, Y.-F. et al. Precision probiotics supplement strategy in aging population based on gut microbiome composition. Brief. Bioinform. 25 , bbae351 (2024). PubMed PubMed Central Google Scholar Latif, A. et al. Probiotics: mechanism of action, health benefits and their application in food industries. Front. Microbiol. 14 , 1216674 (2023). PubMed PubMed Central Google Scholar Khailova, L. et al. Lactobacillus rhamnosus GG and Bifidobacterium longum attenuate lung injury and inflammatory response in experimental sepsis. PLoS ONE 9 , e97861 (2014). PubMed PubMed Central Google Scholar Spacova, I. et al. Lactobacillus rhamnosus probiotic prevents airway function deterioration and promotes gut microbiome resilience in a murine asthma model. Gut Microbes 11 , 1729–1744 (2020). PubMed PubMed Central Google Scholar Walocha, R., Kim, M., Wong-Ng, J., Gobaa, S. & Sauvonnet, N. Organoids and organ-on-chip technology for investigating host–microorganism interactions. Microbes Infect. 26 , 105319 (2024). CAS PubMed Google Scholar Yata, V. K. Ex vivo and miniaturized in vitro models to study microbiota–gut–brain axis. 3 Biotech 14 , 280 (2024). PubMed PubMed Central Google Scholar Krautkramer, K. A., Fan, J. & Bäckhed, F. Gut microbial metabolites as multi-kingdom intermediates. Nat. Rev. Microbiol. 19 , 77–94 (2021). CAS PubMed Google Scholar Mousa, W. K., Chehadeh, F. & Husband, S. Recent advances in understanding the structure and function of the human microbiome. Front. Microbiol. 13 , 825338 (2022). PubMed PubMed Central Google Scholar Ebigbo, N. et al. Optimizing precision probiotics for mitigating graft-versus-host disease. Microorganisms 13 , 706 (2025). CAS PubMed PubMed Central Google Scholar Sanam, M. et al. Bridging two worlds: host microbiota crosstalk in health and dysregulation. Innate Immun. 31 , 17534259251392993 (2025). CAS PubMed PubMed Central Google Scholar Garcia-Vello, P. et al. The lipooligosaccharide of the gut symbiont Akkermansia muciniphila exhibits a remarkable structure and TLR signaling capacity. Nat. Commun. 15 , 8411 (2024). PubMed PubMed Central Google Scholar Zhu, J. et al. Efficacy and safety of Lactobacillus acidophilus LA85 in preventing antibiotic-associated diarrhea: a randomized, placebo-controlled study. Food Sci. Nutr. 13 , e70490 (2025). CAS PubMed PubMed Central Google Scholar García, G. et al. Randomized clinical trials demonstrate the safety assessment of Alkalihalobacillus clausii AO1125 for use as a probiotic in humans. Microorganisms 12 , 2299 (2024). PubMed PubMed Central Google Scholar Quin, C. et al. Probiotic supplementation and associated infant gut microbiome and health: a cautionary retrospective clinical comparison. Sci. Rep. 8 , 8283 (2018). CAS PubMed PubMed Central Google Scholar Mugambi, M. N., Musekiwa, A., Lombard, M., Young, T. & Blaauw, R. Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: a systematic review. BMC Med. Res. Methodol. 13 , 137 (2013). PubMed PubMed Central Google Scholar Rijkers, G. T. et al. Health benefits and health claims of probiotics: bridging science and marketing. Br. J. Nutr. 106 , 1291–1296 (2011). CAS PubMed Google Scholar Lerner, A., Benzvi, C. & Vojdani, A. The potential harmful effects of genetically engineered microorganisms (GEMs) on the intestinal microbiome and public health. Microorganisms 12 , 238 (2024). PubMed PubMed Central Google Scholar Boyle, R. J. et al. Effects of Lactobacillus GG treatment during pregnancy on the development of fetal antigen-specific immune responses. Clin. Exp. Allergy 38 , 1882–1890 (2008). CAS PubMed Google Scholar Gao, X. W., Mubasher, M., Fang, C. Y., Reifer, C. & Miller, L. E. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile -associated diarrhea prophylaxis in adult patients. Am. J. Gastroenterol. 105 , 1636–1641 (2010). PubMed Google Scholar Mohan, R. et al. Effects of Bifidobacterium lactis Bb12 supplementation on body weight, fecal pH, acetate, lactate, calprotectin, and IgA in preterm infants. Pediatr. Res. 64 , 418–422 (2008). PubMed Google Scholar Olivares, M., Castillejo, G., Varea, V. & Sanz, Y. Double-blind, randomised, placebo-controlled intervention trial to evaluate the effects of Bifidobacterium longum CECT 7347 in children with newly diagnosed coeliac disease. Br. J. Nutr. 112 , 30–40 (2014). CAS PubMed Google Scholar Pellino, G. et al. Early postoperative administration of probiotics versus placebo in elderly patients undergoing elective colorectal surgery: a double-blind randomized controlled trial. BMC Surg. 13 , S57 (2013). PubMed PubMed Central Google Scholar Yang, Y. et al. Within-host evolution of a gut pathobiont facilitates liver translocation. Nature 607 , 563–570 (2022). CAS PubMed PubMed Central Google Scholar Montassier, E. et al. Probiotics impact the antibiotic resistance gene reservoir along the human GI tract in a person-specific and antibiotic-dependent manner. Nat. Microbiol. 6 , 1043–1054 (2021). CAS PubMed PubMed Central Google Scholar Mukhopadhya, I. et al. Sporulation capability and amylosome conservation among diverse human colonic and rumen isolates of the keystone starch-degrader Ruminococcus bromii . Environ. Microbiol. 20 , 324–336 (2018). CAS PubMed Google Scholar Uemura, K. et al. Rapid and integrated bacterial evolution analysis unveils gene mutations and clinical risk of Klebsiella pneumoniae . Nat. Commun. 16 , 2917 (2025). CAS PubMed PubMed Central Google Scholar Martin, F.-P. J. et al. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol. Syst. Biol. 4 , 157 (2008). PubMed PubMed Central Google Scholar Rottinghaus, A. G., Ferreiro, A., Fishbein, S. R. S., Dantas, G. & Moon, T. S. Genetically stable CRISPR-based kill switches for engineered microbes. Nat. Commun. 13 , 672 (2022). CAS PubMed PubMed Central Google Scholar George, D. R. et al. A bumpy road ahead for genetic biocontainment. Nat. Commun. 15 , 650 (2024). CAS PubMed PubMed Central Google Scholar Bansal, T. & Garg, S. Probiotics: from functional foods to pharmaceutical products. Curr. Pharm. Biotechnol. 9 , 267–287 (2008). CAS PubMed Google Scholar Cheng, A. G. et al. Design, construction, and in vivo augmentation of a complex gut microbiome. Cell 185 , 3617–3636.e19 (2022). CAS PubMed PubMed Central Google Scholar Furuichi, M. et al. Commensal consortia decolonize Enterobacteriaceae via ecological control. Nature 633 , 878–886 (2024). CAS PubMed PubMed Central Google Scholar Tanoue, T. et al. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature 565 , 600–605 (2019). CAS PubMed Google Scholar Huang, X. et al. Multi-kingdom gut microbiota analyses define bacterial-fungal interplay and microbial markers of pan-cancer immunotherapy across cohorts. Cell Host Microbe 31 , 1930–1943.e4 (2023). CAS PubMed Google Scholar Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105 , 16731–16736 (2008). CAS PubMed PubMed Central Google Scholar Bredon, M. et al. Faecalibaterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors. Oncoimmunology 13 , 2374954 (2024). PubMed PubMed Central Google Scholar Wende, M. et al. Suppression of gut colonization by multidrug-resistant Escherichia coli clinical isolates through cooperative niche exclusion. Nat. Commun. 16 , 5426 (2025). PubMed PubMed Central Google Scholar Depommier, C. et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat. Med. 25 , 1096–1103 (2019). CAS PubMed PubMed Central Google Scholar Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331 , 337–341 (2011). CAS PubMed Google Scholar Atarashi, K. et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163 , 367–380 (2015). CAS PubMed PubMed Central Google Scholar Suez, J. et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514 , 181–186 (2014). CAS PubMed Google Scholar Zeevi, D. et al. Personalized nutrition by prediction of glycemic responses. Cell 163 , 1079–1094 (2015). CAS PubMed Google Scholar Bedu-Ferrari, C. et al. In-depth characterization of a selection of gut commensal bacteria reveals their functional capacities to metabolize dietary carbohydrates with prebiotic potential. mSystems 9 , e0140123 (2024). PubMed PubMed Central Google Scholar Wu, Z. et al. Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: a randomized, controlled, prospective study. Front. Cell. Infect. Microbiol. 12 , 1089991 (2022). CAS PubMed Google Scholar Qin, X. et al. Gut microbiota predict retinopathy in patients with diabetes: a longitudinal cohort study. Appl. Microbiol. Biotechnol. 108 , 497 (2024). CAS PubMed PubMed Central Google Scholar Hu, Y. et al. Causal relationship between gut microbiota and diabetic neuropathy: a Mendelian randomization and 16S rRNA sequencing analysis. Front. Endocrinol. 16 , 1632406 (2025). Google Scholar Xu, M. et al. Causal effects of gut microbiota on diabetic neuropathy: a two-sample Mendelian randomization study. Front. Endocrinol. 15 , 1388927 (2024). Google Scholar Zhang, L. et al. Alterations of the gut microbiota in patients with diabetic nephropathy. Microbiol. Spectr. 10 , e0032422 (2022). PubMed PubMed Central Google Scholar Kaye, D. M. et al. Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease. Circulation 141 , 1393–1403 (2020). CAS PubMed Google Scholar Marques, F. Z. et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation 135 , 964–977 (2017). CAS PubMed Google Scholar Chi, J. et al. Precision probiotics regulate blood glucose, cholesterol, body fat percentage, and weight under eight-week high-fat diet. Metabolites 15 , 642 (2025). CAS PubMed PubMed Central Google Scholar Zhang, D. et al. Short-chain fatty acids in diseases. Cell Commun. Signal. 21 , 212 (2023). PubMed PubMed Central Google Scholar Kostic, A. D. et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14 , 207–215 (2013). CAS PubMed PubMed Central Google Scholar Rubinstein, M. R. et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 14 , 195–206 (2013). CAS PubMed PubMed Central Google Scholar Liang, J. Q. et al. A probiotic formula for modulation of colorectal cancer risk via reducing CRC-associated bacteria. Cells 12 , 1244 (2023). CAS PubMed PubMed Central Google Scholar Chowdhury, S. et al. Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nat. Med. 25 , 1057–1063 (2019). CAS PubMed PubMed Central Google Scholar Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569 , 655–662 (2019). CAS PubMed Google Scholar Franzosa, E. A. et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat. Microbiol. 4 , 293–305 (2019). CAS PubMed Google Scholar Ning, L. et al. Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts. Nat. Commun. 14 , 7135 (2023). CAS PubMed PubMed Central Google Scholar Govaert, M. et al. Survival of probiotic bacterial cells in the upper gastrointestinal tract and the effect of the surviving population on the colonic microbial community activity and composition. Nutrients 16 , 2791 (2024). CAS PubMed PubMed Central Google Scholar Cao, F. et al. Engineering clinically relevant probiotics with switchable ‘nano-promoter’ and ‘nano-effector’ for precision tumor therapy. Adv. Mater. 36 , e2304257 (2024). PubMed Google Scholar Mainali, K., Bewick, S., Vecchio-Pagan, B., Karig, D. & Fagan, W. F. Detecting interaction networks in the human microbiome with conditional Granger causality. PLoS Comput. Biol. 15 , e1007037 (2019). CAS PubMed PubMed Central Google Scholar Angermueller, C., Pärnamaa, T., Parts, L. & Stegle, O. Deep learning for computational biology. Mol. Syst. Biol. 12 , 878 (2016). PubMed PubMed Central Google Scholar Zhang, Y. et al. Screening antimicrobial peptides and probiotics using multiple deep learning and directed evolution strategies. Acta Pharm. Sin. B 14 , 3476–3492 (2024). CAS PubMed PubMed Central Google Scholar Hanson, B. et al. Garbage in, garbage out: mitigating risks and maximizing benefits of AI in research. Nature 623 , 28–31 (2023). CAS PubMed Google Scholar Wu, G. et al. A core microbiome signature as an indicator of health. Cell 187 , 6550–6565.e11 (2024). CAS PubMed Google Scholar Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630 , 493–500 (2024). CAS PubMed PubMed Central Google Scholar Passaro, S. et al. Boltz-2: towards accurate and efficient binding affinity prediction. Preprint at bioRxiv https://doi.org/10.1101/2025.06.14.659707 (2025). Zhao, H. et al. Protein–peptide docking with a rational and accurate diffusion generative model. Nat. Mach. Intell. 7 , 1308–1321 (2025). Google Scholar Mooney, C., Haslam, N. J., Pollastri, G. & Shields, D. C. Towards the improved discovery and design of functional peptides: common features of diverse classes permit generalized prediction of bioactivity. PLoS ONE 7 , e45012 (2012). CAS PubMed PubMed Central Google Scholar Fernández-Díaz, R. et al. AutoPeptideML: a study on how to build more trustworthy peptide bioactivity predictors. Bioinformatics 40 , btae555 (2024). PubMed PubMed Central Google Scholar Du, Z., Ding, X., Xu, Y. & Li, Y. UniDL4BioPep: a universal deep learning architecture for binary classification in peptide bioactivity. Brief. Bioinform. 24 , bbad135 (2023). PubMed Google Scholar Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29 , 845–854 (2013). CAS PubMed PubMed Central Google Scholar Dominguez, C., Boelens, R. & Bonvin, A. M. J. J. HADDOCK: a protein–protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125 , 1731–1737 (2003). CAS PubMed Google Scholar Stark, H. et al. BoltzGen: toward universal binder design. Preprint at bioRxiv https://doi.org/10.1101/2025.11.20.689494 (2025). Graber, D. et al. Resolving data bias improves generalization in binding affinity prediction. Nat. Mach. Intell. 7 , 1713–1725 (2025). PubMed PubMed Central Google Scholar Wu, L. et al. Data-driven prediction of colonization outcomes for complex microbial communities. Nat. Commun. 15 , 2406 (2024). CAS PubMed PubMed Central Google Scholar Carr, A., Baliga, N. S., Diener, C. & Gibbons, S. M. Personalized Clostridioides difficile engraftment risk prediction and probiotic therapy assessment in the human gut. Cell Syst. 16 , 101367 (2025). CAS PubMed PubMed Central Google Scholar Heinken, A. et al. Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine. Nat. Biotechnol. 41 , 1320–1331 (2023). CAS PubMed PubMed Central Google Scholar Quinn-Bohmann, N. et al. Microbial community-scale metabolic modeling predicts personalized short chain fatty acid production profiles in the human gut. Preprint at bioRxiv https://doi.org/10.1101/2023.02.28.530516 (2023). Silva-Andrade, C. et al. A machine-learning approach for predicting butyrate production by microbial consortia using metabolic network information. PeerJ 13 , e19296 (2025). PubMed PubMed Central Google Scholar Gutierrez, M. W. et al. Early-life gut mycobiome core species modulate metabolic health in mice. Nat. Commun. 16 , 1467 (2025). CAS PubMed PubMed Central Google Scholar Pattaroni, C. et al. Early life inter-kingdom interactions shape the immunological environment of the airways. Microbiome 10 , 34 (2022). PubMed PubMed Central Google Scholar Aminian-Dehkordi, J., Parsa, M., Dickson, A. & Mofrad, M. R. K. SIMBA-GNN: mechanistic graph learning for microbiome prediction. npj Syst. Biol. Appl. 12 , 8 (2025). PubMed PubMed Central Google Scholar Huang, H. et al. The mycobiome as integral part of the gut microbiome: crucial role of symbiotic fungi in health and disease. Gut Microbes 16 , 2440111 (2024). PubMed PubMed Central Google Scholar Sulaimany, S., Farahmandi, K. & Mafakheri, A. Computational prediction of new therapeutic effects of probiotics. Sci. Rep. 14 , 11932 (2024). CAS PubMed PubMed Central Google Scholar Matsubara, V. H., Wang, Y., Bandara, H. M. H. N., Mayer, M. P. A. & Samaranayake, L. P. Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation. Appl. Microbiol. Biotechnol. 100 , 6415–6426 (2016). CAS PubMed Google Scholar Thiele, I. et al. Personalized whole-body models integrate metabolism, physiology, and the gut microbiome. Mol. Syst. Biol. 16 , e8982 (2020). PubMed PubMed Central Google Scholar Quinn, R. A. et al. Niche partitioning of a pathogenic microbiome driven by chemical gradients. Sci. Adv. 4 , eaau1908 (2018). PubMed PubMed Central Google Scholar Mougi, A. pH adaptation stabilizes bacterial communities. npj Biodivers. 3 , 32 (2024). CAS PubMed PubMed Central Google Scholar Harcombe, W. R. et al. Metabolic resource allocation in individual microbes determines ecosystem interactions and spatial dynamics. Cell Rep. 7 , 1104–1115 (2014). CAS PubMed PubMed Central Google Scholar McCoubrey, L. E. et al. Active machine learning for formulation of precision probiotics. Int. J. Pharm. 616 , 121568 (2022). CAS PubMed Google Scholar Cenikj, G. et al. From language models to large-scale food and biomedical knowledge graphs. Sci. Rep. 13 , 7815 (2023). CAS PubMed PubMed Central Google Scholar Shin, E., Bhat, A. G. & Ramanathan, M. Large language models for clinical trial protocol assessments. Clin. Pharmacol. Ther. 119 , 393–402 (2026). PubMed Google Scholar Athaluri, S. A. et al. Exploring the boundaries of reality: investigating the phenomenon of artificial intelligence hallucination in scientific writing through ChatGPT references. Cureus 15 , e37432 (2023). PubMed PubMed Central Google Scholar Hatem, R., Simmons, B. & Thornton, J. E. A call to address AI ‘hallucinations’ and how healthcare professionals can mitigate their risks. Cureus 15 , e44720 (2023). PubMed PubMed Central Google Scholar Jiang, J. et al. Artificial intelligence in bioinformatics: a survey. Brief. Bioinform. 26 , bbaf576 (2025). PubMed PubMed Central Google Scholar Anh-Hoang, D., Tran, V. & Nguyen, L.-M. Survey and analysis of hallucinations in large language models: attribution to prompting strategies or model behavior. Front. Artif. Intell. 8 , 1622292 (2025). PubMed PubMed Central Google Scholar Lin, S., Hilton, J. & Evans, O. TruthfulQA: measuring how models mimic human falsehoods. In Proc . 60th Annu. Meet. Assoc. Comput. Linguist. 3266–3289 (ACL, 2022). Zhao, Y. & Zhang, Y. HalluClean: a unified framework to combat hallucinations in LLMs. Proc. AAAI Conf. Artif. Intell. 40 , 36092–36100 (2026). Google Scholar Matsumoto, N. et al. KRAGEN: a knowledge graph-enhanced RAG framework for biomedical problem solving using large language models. Bioinformatics 40 , btae353 (2024). CAS PubMed PubMed Central Google Scholar Gargari, O. K. & Habibi, G. Enhancing medical AI with retrieval-augmented generation: a mini narrative review. Digit. Health 11 , 20552076251337177 (2025). PubMed PubMed Central Google Scholar Pan, G., Chodnekar, V., Roy, A. & Wang, H. A cost–benefit analysis of on-premise large language model deployment: breaking even with commercial LLM services. Preprint at https://doi.org/10.48550/arXiv.2509.18101 (2025). World Health Organization. Ethics and Governance of Artificial Intelligence for Health : Guidance on Large Multi-Modal Models (WHO, 2024). Baliga, S., Muglikar, S. & Kale, R. Salivary pH: a diagnostic biomarker. J. Indian Soc. Periodontol. 17 , 461–465 (2013). PubMed PubMed Central Google Scholar Brinck, J. E. et al. Intestinal pH: a major driver of human gut microbiota composition and metabolism. Nat. Rev. Gastroenterol. Hepatol. 22 , 639–656 (2025). PubMed Google Scholar Lin, Y.-P., Chen, W.-C., Cheng, C.-M. & Shen, C.-J. Vaginal pH value for clinical diagnosis and treatment of common vaginitis. Diagnostics 11 , 1996 (2021). PubMed PubMed Central Google Scholar Brooks, S. G., Mahmoud, R. H., Lin, R. R., Fluhr, J. W. & Yosipovitch, G. The skin acid mantle: an update on skin pH. J. Invest. Dermatol. 145 , 509–521 (2025). CAS PubMed Google Scholar Dickson, R. P. et al. Radiographic honeycombing and altered lung microbiota in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 200 , 1544–1547 (2019). CAS PubMed PubMed Central Google Scholar Nicola, T. et al. A lactobacilli-based inhaled live biotherapeutic product attenuates pulmonary neutrophilic inflammation. Nat. Commun. 15 , 7113 (2024). CAS PubMed PubMed Central Google Scholar Zawistowska-Rojek, A. et al. Evaluating the quality of selected commercial probiotic products, both dietary supplements and foods for special medical purposes. Foods 15 , 373 (2026). CAS PubMed PubMed Central Google Scholar Drago, L., Rodighiero, V., Celeste, T., Rovetto, L. & De Vecchi, E. Microbiological evaluation of commercial probiotic products available in the USA in 2009. J. Chemother. 22 , 373–377 (2010). CAS PubMed Google Scholar Vesa, T., Pochart, P. & Marteau, P. Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment. Pharmacol. Ther. 14 , 823–828 (2000). CAS PubMed Google Scholar Cai, S. et al. Lactobacillus rhamnosus GG activation of dendritic cells and neutrophils depends on the dose and time of exposure. J. Immunol. Res. 2016 , 7402760 (2016). PubMed PubMed Central Google Scholar Weese, J. S. & Martin, H. Assessment of commercial probiotic bacterial contents and label accuracy. Can. Vet. J. 52 , 43–46 (2011). PubMed PubMed Central Google Scholar Oozeer, R. et al. Survival of Lactobacillus casei in the human digestive tract after consumption of fermented milk. Appl. Environ. Microbiol. 72 , 5615–5617 (2006). CAS PubMed PubMed Central Google Scholar Arioli, S., Koirala, R., Taverniti, V., Fiore, W. & Guglielmetti, S. Quantitative recovery of viable Lactobacillus paracasei CNCM I-1572 ( L . casei DG®) after gastrointestinal passage in healthy adults. Front. Microbiol. 9 , 1720 (2018). PubMed PubMed Central Google Scholar Goossens, D. et al. Survival of the probiotic, L . plantarum 299v and its effects on the faecal bacterial flora, with and without gastric acid inhibition. Dig. Liver Dis. 37 , 44–50 (2005). CAS PubMed Google Scholar Wang, J., Zhang, J., Liu, W., Zhang, H. & Sun, Z. Metagenomic and metatranscriptomic profiling of Lactobacillus casei Zhang in the human gut. npj Biofilms Microbiomes 7 , 55 (2021). PubMed PubMed Central Google Scholar Basu, S., Paul, D. K., Ganguly, S., Chatterjee, M. & Chandra, P. K. Efficacy of high-dose Lactobacillus rhamnosus GG in controlling acute watery diarrhea in Indian children: a randomized controlled trial. J. Clin. Gastroenterol. 43 , 208–213 (2009). PubMed Google Scholar Salamat, S., Jahan-Mihan, A., Gharibvand, L., Reza Tabandeh, M. & Mansoori, A. Multi-species synbiotic supplementation increased fecal short chain fatty acids and anti-inflammatory cytokine interleukin-10 in adult men with dyslipidemia; a randomized, double-blind, clinical trial. Cytokine 179 , 156608 (2024). CAS PubMed Google Scholar Alander, M. et al. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 65 , 351–354 (1999). CAS PubMed PubMed Central Google Scholar Goossens, D. et al. The effect of Lactobacillus plantarum 299v on the bacterial composition and metabolic activity in faeces of healthy volunteers: a placebo-controlled study on the onset and duration of effects. Aliment. Pharmacol. Ther. 18 , 495–505 (2003). CAS PubMed Google Scholar Radicioni, M. et al. Survival of L . casei DG® ( Lactobacillus paracasei CNCMI1572) in the gastrointestinal tract of a healthy paediatric population. Eur. J. Nutr. 58 , 3161–3170 (2019). CAS PubMed Google Scholar Yin, X., Lee, B., Zaragoza, J. & Marco, M. L. Dietary perturbations alter the ecological significance of ingested Lactobacillus plantarum in the digestive tract. Sci. Rep. 7 , 7267 (2017). PubMed PubMed Central Google Scholar Maltby, R., Leatham-Jensen, M. P., Gibson, T., Cohen, P. S. & Conway, T. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E . coli O157:H7 in the mouse intestine. PLoS ONE 8 , e53957 (2013). CAS PubMed PubMed Central Google Scholar Deriu, E. et al. Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 14 , 26–37 (2013). CAS PubMed PubMed Central Google Scholar Jankowska, A., Laubitz, D., Antushevich, H., Zabielski, R. & Grzesiuk, E. Competition of Lactobacillus paracasei with Salmonella enterica for adhesion to Caco-2 cells. J. Biomed. Biotechnol. 2008 , 357964 (2008). PubMed PubMed Central Google Scholar Orlando, A., Linsalata, M., Notarnicola, M., Tutino, V. & Russo, F. Lactobacillus GG restoration of the gliadin induced epithelial barrier disruption: the role of cellular polyamines. BMC Microbiol. 14 , 19 (2014). PubMed PubMed Central Google Scholar Guo, S. et al. Secretions of Bifidobacterium infantis and Lactobacillus acidophilus protect intestinal epithelial barrier function. J. Pediatr. Gastroenterol. Nutr. 64 , 404–412 (2017). CAS PubMed Google Scholar Gao, J. et al. A novel postbiotic from Lactobacillus rhamnosus GG with a beneficial effect on intestinal barrier function. Front. Microbiol. 10 , 477 (2019). PubMed PubMed Central Google Scholar Prete, R. et al. Beneficial bile acid metabolism from Lactobacillus plantarum of food origin. Sci. Rep. 10 , 1165 (2020). CAS PubMed PubMed Central Google Scholar Gui, L. et al. Lactobacillus rhamnosus GG maintains gut microbiota stability and promotes intestinal adaptation via activated intestinal farnesoid X receptor signaling in short bowel syndrome. Commun. Biol. 8 , 816 (2025). CAS PubMed PubMed Central Google Scholar Yao, L. et al. A selective gut bacterial bile salt hydrolase alters host metabolism. eLife 7 , e37182 (2018). PubMed PubMed Central Google Scholar Makishima, M. et al. Identification of a nuclear receptor for bile acids. Science 284 , 1362–1365 (1999). CAS PubMed Google Scholar Boonma, P. et al. Probiotic VSL#3 treatment reduces colonic permeability and abdominal pain symptoms in patients with irritable bowel syndrome. Front. Pain Res. 2 , 691689 (2021). Google Scholar Ahlroos, T. & Tynkkynen, S. Quantitative strain-specific detection of Lactobacillus rhamnosus GG in human faecal samples by real-time PCR. J. Appl. Microbiol. 106 , 506–514 (2009). CAS PubMed Google Scholar Sequeira, I. R., Lentle, R. G., Kruger, M. C. & Hurst, R. D. Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability. PLoS ONE 9 , e99256 (2014). PubMed PubMed Central Google Scholar Adriaanse, M. P. M. et al. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment. Pharmacol. Ther. 37 , 482–490 (2013). CAS PubMed Google Scholar Tibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I. & Bjarnason, I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 123 , 450–460 (2002). PubMed Google Scholar D’Haens, G. et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm. Bowel Dis. 18 , 2218–2224 (2012). PubMed Google Scholar Borruel, N. et al. Increased mucosal tumour necrosis factor α production in Crohn’s disease can be downregulated ex vivo by probiotic bacteria. Gut 51 , 659–664 (2002). CAS PubMed PubMed Central Google Scholar Zhou, S. et al. Probiotic treatment induces changes in intestinal microbiota but does not alter SCFA levels in peritoneal dialysis patients — a randomized, placebo-controlled trial. Sci. Rep. 14 , 31413 (2024). CAS PubMed PubMed Central Google Scholar Gibson, G. R., Beatty, E. R., Wang, X. & Cummings, J. H. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108 , 975–982 (1995). CAS PubMed Google Scholar Kruse, H. P., Kleessen, B. & Blaut, M. Effects of inulin on faecal bifidobacteria in human subjects. Br. J. Nutr. 82 , 375–382 (1999). CAS PubMed Google Scholar Anzawa, D. et al. Effects of synbiotics containing Bifidobacterium animalis subsp. lactis GCL2505 and inulin on intestinal bifidobacteria: a randomized, placebo-controlled, crossover study. Food Sci. Nutr. 7 , 1828–1837 (2019). CAS PubMed PubMed Central Google Scholar

Source: Nature

Read Original Source →